| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,931 |
2,714 |
$127K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,229 |
6,987 |
$126K |
| 80061 |
Lipid panel |
8,047 |
7,719 |
$111K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,747 |
3,435 |
$87K |
| 80053 |
Comprehensive metabolic panel |
7,637 |
7,285 |
$83K |
| 85027 |
|
10,725 |
10,185 |
$72K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,950 |
1,857 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,019 |
986 |
$52K |
| 82274 |
|
2,916 |
2,821 |
$48K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,350 |
4,181 |
$44K |
| 85007 |
|
10,725 |
10,184 |
$37K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,338 |
1,289 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
7,679 |
6,838 |
$24K |
| 81001 |
|
6,892 |
6,608 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,630 |
796 |
$20K |
| 84153 |
|
1,038 |
993 |
$20K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,029 |
1,927 |
$18K |
| 82043 |
|
2,426 |
2,308 |
$15K |
| 82570 |
|
2,443 |
2,326 |
$13K |
| 86738 |
|
742 |
682 |
$12K |
| 82607 |
|
694 |
652 |
$11K |
| 86328 |
|
554 |
548 |
$10K |
| 84439 |
|
1,021 |
980 |
$10K |
| 87088 |
|
1,164 |
1,092 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,274 |
1,045 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,098 |
1,035 |
$9K |
| 80074 |
|
178 |
178 |
$9K |
| 87806 |
|
338 |
330 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
141 |
132 |
$7K |
| 81000 |
|
2,100 |
1,927 |
$6K |
| 86769 |
|
130 |
128 |
$3K |
| 86803 |
|
205 |
203 |
$3K |
| 85651 |
|
846 |
811 |
$3K |
| 84436 |
|
431 |
399 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
72 |
67 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
72 |
67 |
$3K |
| 84479 |
|
366 |
340 |
$2K |
| 86317 |
|
68 |
63 |
$1K |
| 82947 |
|
362 |
342 |
$1K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
76 |
62 |
$1K |
| 87276 |
|
95 |
89 |
$1K |
| 86592 |
|
281 |
266 |
$1K |
| 87275 |
|
95 |
89 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
15 |
$1K |
| 86140 |
|
158 |
151 |
$828.64 |
| 87185 |
|
170 |
153 |
$798.95 |
| 85730 |
|
107 |
100 |
$666.40 |
| P9615 |
Catheterization for collection of specimen(s) (multiple patients) |
294 |
258 |
$481.18 |
| 85610 |
|
105 |
98 |
$427.81 |
| 87899 |
|
28 |
28 |
$316.93 |
| 83001 |
|
15 |
13 |
$291.10 |
| 82950 |
|
38 |
38 |
$190.50 |
| 87338 |
|
12 |
12 |
$188.04 |
| 83655 |
|
12 |
12 |
$155.56 |
| 82042 |
|
20 |
14 |
$113.81 |
| 82565 |
|
12 |
12 |
$62.33 |
| 84520 |
|
12 |
12 |
$48.03 |
| 84156 |
|
12 |
12 |
$48.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
632 |
608 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
57 |
55 |
$0.00 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
14 |
14 |
$0.00 |